Percutaneous transluminal coronary angioplasty: an added modality for the treatment of the patient with coronary heart disease
Iannone, L.A.; Brown, T.M.; Phillips, S.J.; Wickemeyer, W.J.; Zeff, R.H.; Wheeler, W.S.; Kongtahworn, C.; Rough, R.R.; Skinner, J.R.; Toon, R.S.
Cardiologia 28(7): 625-633
1983
ISSN/ISBN: 0393-1978 PMID: 6234906 Document Number: 216258
Experience with transluminal coronary angioplasty is discussed. Dilatation was attempted in 419 patients and 450 lesions. Patients' age ranged from 30-84 yr. The procedure was successful in 81.6% of cases. Complication consisted of ventricular fibrillation (1.4%), acute myocaridal infarction (4.3%) emergency bypass surgery (8.9%). Overall mortality was 1.2%: 0.07% in the laboratory or following emergency surgery, 0.05% within the 1st mo. and 0.08% beyond the 1st mo. after dilatation. The risk-benefit ratio of the procedure is equal to or better than that of coronary bypass surgery, and dilatation can be offered to elderly patients and to patients with multivessel disease.